Ostarine, also known as MK-2866 or Enobosarm, is a selective androgen receptor modulator (SARM) that is currently being researched for its potential use in treating muscle wasting diseases, osteoporosis, and hormone replacement therapy. SARMs for sales like Ostarine works by selectively binding to androgen receptors in the body, specifically in skeletal muscle and bone tissue.
Description
1. MECHANISM OF ACTION
MK-2866 operates as a selective androgen receptor modulator (SARM) engineered to bind with high affinity to androgen receptors, triggering tissue-selective anabolic activity. By driving gene expression pathways specifically within muscle tissue and bone matrix architectures, the compound promotes nitrogen retention and lean muscle maintenance while avoiding significant systemic crossover. This highly target-focused affinity yields an authoritative experimental baseline for studying cell-mediated growth cycles and localized tissue homeostasis.
2. THE RETAIL & KIT ARCHITECTURE
- Configuration: 50 Tablets / Box (2 x 25 tabs)
- Concentration: 15 mg per Tablet
- Formulation: Micronized Oral Matrix
3. TECHNICAL SPECIFICATIONS
| Attribute | Details |
|---|---|
| Active Compound | MK-2866 |
| Concentration Profile | 15 mg / tablet |
| Molecular Structure | C19H14F3N3O3 |
| Composition Base | Micronized Oral Tablet Matrix |
| SKU Number | ORA-MK2866-50T |




